{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:47:06Z","timestamp":1793278026888,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302784"],"award-info":[{"award-number":["81302784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023sfy008"],"award-info":[{"award-number":["2023sfy008"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2208085MH283"],"award-info":[{"award-number":["2208085MH283"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.yexcr.2025.114871","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:04:08Z","timestamp":1766534648000},"page":"114871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the Gas6-TAM-SOCS1\/3 axis: CP-25 attenuates macrophage dysfunction in primary Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"455","author":[{"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxue","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1869-4106","authenticated-orcid":false,"given":"Huaxun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114871_bib1","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kez142","article-title":"Treatment of Sjogren's syndrome: current therapy and future directions","author":"Fox","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.yexcr.2025.114871_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70297","article-title":"Sj\u679agren's syndrome: epidemiology, classification criteria, molecular pathogenesis, diagnosis, and treatment","author":"Hu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.yexcr.2025.114871_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","author":"Brito-Zeron","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.yexcr.2025.114871_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2017.04.003","article-title":"Innate immunity in Sjogren's syndrome","author":"Kiripolsky","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.yexcr.2025.114871_bib5","article-title":"The critical involvement of monocytes\/macrophages in the pathogenesis of primary Sjogren's syndrome: new evidence from Mendelian randomization and single-cell sequencing","volume":"2024","author":"Ding","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexcr.2025.114871_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-024-03340-7","article-title":"The role of M1\/M2 macrophage polarization in primary Sjogren's syndrome","author":"Chen","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.yexcr.2025.114871_bib7","first-page":"185","article-title":"Type I interferon signature in Sjogren's syndrome: pathophysiological and clinical implications","author":"Marketos","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.yexcr.2025.114871_bib8","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","author":"Gottenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.yexcr.2025.114871_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41584-023-00991-9","article-title":"A leading role for interferon as a treatment target in Sjogren syndrome","author":"Verstappen","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.yexcr.2025.114871_bib10","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/rheumatology\/key360","article-title":"Innate immunity and interferons in the pathogenesis of Sjogren's syndrome","volume":"2021","author":"Bodewes","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.yexcr.2025.114871_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","article-title":"The clearance of dead cells by efferocytosis","author":"Boada-Romero","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114871_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2025.114871_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-023-00846-8","article-title":"Therapeutic targeting of the functionally elusive TAM receptor family","author":"Miao","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yexcr.2025.114871_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11684-024-1067-5","article-title":"Adenosine deaminase 2 regulates the activation of the toll-like receptor 9 in response to nucleic acids","author":"Dong","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.yexcr.2025.114871_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.07.007","article-title":"Sensing and clearance of apoptotic cells","author":"Nagata","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.yexcr.2025.114871_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12974-020-02041-7","article-title":"Mer regulates microglial\/macrophage M1\/M2 polarization and alleviates neuroinflammation following traumatic brain injury","author":"Wu","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.yexcr.2025.114871_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107452","article-title":"Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2025.114871_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112557","article-title":"Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation","author":"Han","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114871_bib19","article-title":"CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114871_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109432","article-title":"Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis","author":"Tang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114871_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41401-020-00510-6","article-title":"CP-25, a compound derived from paeoniflorin: research advances on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases","author":"Yang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexcr.2025.114871_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2019.00057","article-title":"The regulatory effects of paeoniflorin and its derivative Paeoniflorin-6'-O-Benzene sulfonate CP-25 on inflammation and immune diseases","author":"Tu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114871_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bcpt.13025","article-title":"CP-25 alleviates experimental Sjogren's syndrome features in NOD\/Ltj mice and modulates T lymphocyte subsets","author":"Gu","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yexcr.2025.114871_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41374-020-0453-0","article-title":"CP-25 alleviates antigen-induced experimental Sjogren's syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration","author":"Wu","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.yexcr.2025.114871_bib25","article-title":"Alleviating effect of paeoniflorin-6\u2032-O-benzene sulfonate in antigen-induced experimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway","volume":"2020","author":"Chen","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114871_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41374-020-0453-0","article-title":"CP-25 alleviates antigen-induced experimental Sj\u00f6gren's syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration","author":"Wu","year":"2021","journal-title":"Lab. Invest."},{"key":"10.1016\/j.yexcr.2025.114871_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bcpt.13025","article-title":"CP\u201025 alleviates experimental Sj\u00f6gren's syndrome features in NOD\/Ltj mice and modulates T lymphocyte subsets","author":"Gu","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yexcr.2025.114871_bib28","article-title":"CP-25 ameliorates dysfunction in the M3R-IP3R-Ca2+-AQP5 signaling pathway by inhibiting ERS in primary Sj\u00f6gren\u2019s syndrome","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114871_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-021-00415-5","article-title":"Key metalloproteinase-mediated pathways in the kidney","author":"Wozniak","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yexcr.2025.114871_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4813795","article-title":"Sjogren's syndrome and TAM receptors: a possible contribution to disease onset","author":"Witas","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.yexcr.2025.114871_bib31","article-title":"Gas6\/TAM system as potential biomarker for multiple sclerosis prognosis","volume":"2024","author":"D'Onghia","year":"2024","journal-title":"Front. Immunol."},{"issue":"2025","key":"10.1016\/j.yexcr.2025.114871_bib32","article-title":"Clinical significance of TAM receptor in the minor salivary glands of patients with Sjogren's disease","author":"Choi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114871_bib33","first-page":"1387","article-title":"CP-25, a compound derived from paeoniflorin: research advances on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexcr.2025.114871_bib34","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41374-020-0453-0","article-title":"CP-25 alleviates antigen-induced experimental Sjogren's syndrome in mice by inhibiting JAK1-STAT1\/2-CXCL13 signaling and interfering with B-cell migration","author":"Wu","year":"2021","journal-title":"Lab. Invest."},{"issue":"2023","key":"10.1016\/j.yexcr.2025.114871_bib35","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1097\/CM9.0000000000002539","article-title":"Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjogren's syndrome","author":"Li","year":"2023","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.yexcr.2025.114871_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","article-title":"Targeting SOCS proteins to control JAK-STAT signalling in disease","author":"Durham","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yexcr.2025.114871_bib37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11481-018-9793-6","article-title":"The neuro-immune-regulators (NIREGs) promote tissue resilience; a vital component of the host's defense strategy against neuroinflammation","author":"Bedoui","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114871_bib38","article-title":"TREM2 overexpression rescues cognitive deficits in APP\/PS1 transgenic mice by reducing neuroinflammation via the JAK\/STAT\/SOCS signaling pathway","author":"Bosco Ruganzu","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.yexcr.2025.114871_bib39","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1073\/pnas.1821601116","article-title":"STAT6 induces expression of Gas6 in macrophages to clear apoptotic neutrophils and resolve inflammation","volume":"2019","author":"Nepal","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.yexcr.2025.114871_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41420-025-02507-8","article-title":"GAS6\/AXL signaling promotes M2 microglia efferocytosis to alleviate neuroinflammation in sepsis-associated encephalopathy","author":"Tang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2025.114871_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.devcel.2016.06.029","article-title":"The dynamics of apoptotic cell clearance","author":"Elliott","year":"2016","journal-title":"Dev. Cell"},{"key":"10.1016\/j.yexcr.2025.114871_bib42","doi-asserted-by":"crossref","first-page":"33335","DOI":"10.1074\/jbc.M111.263020","article-title":"Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK)","volume":"2011","author":"Thorp","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114871_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41419-025-07480-9","article-title":"Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?","volume":"2025","author":"Malikova","year":"2025","journal-title":"Cell Death Dis."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725004719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725004719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:20:43Z","timestamp":1785968443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725004719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0014482725004719"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114871","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the Gas6-TAM-SOCS1\/3 axis: CP-25 attenuates macrophage dysfunction in primary Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114871"}}